Ribonuclease/angiogenin Inhibitor 1 (RNH1) (Middle Region) Peptide
Quick Overview for Ribonuclease/angiogenin Inhibitor 1 (RNH1) (Middle Region) Peptide (ABIN8110580)
Target
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- RNH1 Peptide - middle region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-RNH1 antibody ( ARP57821_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
-
Background
-
Background Information: RNH1 is the inhibitor of pancreatic RNase and angiogenin. RNH1 may also function in the modulation of cellular activities.
Alternative Symbols: MGC18200, MGC4569, MGC54054, RAI, RNH
-
Molecular Weight
- 50kDa
-
Gene ID
- 6050
-
NCBI Accession
- NP_976321
-
UniProt
- P13489
Target
-